New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2014
07:06 EDTCRMECardiome reports Q4 EPS (53c), consensus (22c)
Reports Q4 revenue $3.9M, consensus $3.17M; The net loss in Q4 was largely due to an increase in SG&A expenses incurred to support the commercialization of BRINAVESS and AGGRASTAT.
News For CRME From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 17, 2014
08:38 EDTCRMECardiome enters commercialization agreement with Aspen for BRINAVESS
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use